Recurrent nomo1 gene deletion is a potential clinical marker in early-onset colorectal cancer and is involved in the regulation of cell migration

HIGHLIGHTS

• who: Jésica Pérez-García et al. from the Institute of Biomedical Research of Salamanca (IBSAL), SACYL-University of Salamanca-CSIC, Salamanca, Spain have published the research: Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration, in the Journal: (JOURNAL) of 27/01/2022
• what: The authors show that in 30% of EOCRCs with heterozygous of there were pathogenic mutations in this suggesting that can be inactivated by or mutation in EOCRC. In the study , the authors used CRISPR . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.